Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle:The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Compared with men, women are at increased risk of depression, especially at several reproductive-related lifecycle points. This may be partially due to changing levels of estrogen, a hormone that can affect levels of neurotransmitters and neural proteins. As estrogen levels vary throughout the lifespan, risk of depression in women also varies, and not all treatments are appropriate or effective at all times. In adolescence, onset of depression may be associated with onset of puberty, but treating underage girls with antidepressants can risk suicidality. In females of childbearing age, mood disturbances associated with menstrual cycles signal a risk for later full-blown major depressive disorder. In depressed pregnant and postpartum women, risks of treatment versus risks of nontreatment are intricate and require case-by-case evaluation. In perimenopause, vasomotor symptoms may be harbingers of oncoming depression and also may signal the presence of dysregulated hormones and neurotransmitters. Relieving vasomotor symptoms may be a necessary dimension of treating depression. In postmenopause, response to selected antidepressants may depend on whether the patient is also taking hormone-replacement therapy. To attain optimal outcomes, modern psychopharmacologists must tailor treatment of depression to a woman's reproductive stage of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207 · cited 2×
“The difference in prevalence between genders begins in early adolescence and persists until women are in their mid-50s.(9) Another study of 9,792 British adults(10) found that, from 16-54 years of age, depression was twice as likely in women than in men, but depression in postmenopause-aged females (55-64 years) retur…”
BackgroundCohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
FAVA, M., ALPERT, J. E., CARMIN, C. N., WISNIEWSKI, S. R., TRIVEDI, M. H., BIGGS, M. M., SHORES-WILSON, K., MORGAN, D., SCHWARTZ, T., BALASUBRAMANI, G. K., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291704002612 · Cited by 406
BEBBINGTON, P. E., DUNN, G., JENKINS, R., LEWIS, G., BRUGHA, T., FARRELL, M., & MELTZER, H. (1998) · Psychological Medicine · doi:10.1017/s0033291797006077 · Cited by 330
Depression during Pregnancy: Overview of Clinical Factors
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Clinical Drug Investigation · doi:10.2165/00044011-200424030-00004 · Cited by 317
Wagner, G., Sinsel, E., Sobanski, T., Köhler, S., Marinou, V., Mentzel, H.-J., Sauer, H., & Schlösser, R. G. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.025 · Cited by 278
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
Thase, M. E., Entsuah, R., Cantillon, M., & Kornstein, S. G. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.609 · Cited by 201
Österlund, M. K., Keller, E., & Hurd, Y. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00443-1 · Cited by 174 · cited 2×
“The human amygdala is especially rich in estrogen receptors.(21) Anxiety is associated with the amygdala in humans(22) and is a frequent symptom of MDD.”
BackgroundFrye, C. A., & Walf, A. A. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.2.306 · Cited by 172 · cited 1×
“Administration of estrogen to the amygdala of ovariectomized rats decreases anxious behaviors.(22)”
BackgroundEstrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0398com · Cited by 115
Cited by
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Slavich, G. M., & Sacher, J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05326-9 · Cited by 383
“These effects emerge early on in brain development and continue throughout adolescence (Juraska et al. 2013) and adulthood (Wise et al. 2008).”
Sex differences in psychopathology: of gonads, adrenals and mental illness
Solomon, M. B., & Herman, J. P. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.033 · Cited by 272
“, serotonin, dopamine) [73], periodic E2 withdrawal consequent to stress, parturition, and even the normal cycle may make women more sensitive to stress-related psychopathologies.”
From synapse to nucleus: Novel targets for treating depression
Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98
Cripe, S. M., Frederick, I. O., Qiu, C., & Williams, M. A. (2011) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2010.01182.x · Cited by 86
Metadata
- Authors
- Wise, D. D., Felker, A., & Stahl, S. M.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-08
- Volume
- 13
- Issue
- 8
- Pages
- 647-662
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2413621638
- Cited by
- 42
- References
- 10
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle:The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology. https://app.cochat.ai/papers/10.1017/s1092852900013742
- The paper
- Wise, D. D., Felker, A., & Stahl, S. M. (2008). Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle:The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology. CNS Spectrums. https://doi.org/10.1017/s1092852900013742
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.